The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,346K data for 622K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

12 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Identification of novel aminopiperidine derivatives for antibacterial activity against Gram-positive bacteria.EBI
Research Laboratories Ildong Pharmaceutical
Macrolactin N, a new peptide deformylase inhibitor produced by Bacillus subtilis.EBI
Korea Research Institute Of Bioscience And Biotechnology
Acylprolinamides: a new class of peptide deformylase inhibitors with in vivo antibacterial activity.EBI
Glaxosmithkline
Flavimycins A and B, dimeric 1,3-dihydroisobenzofurans with peptide deformylase inhibitory activity from Aspergillus flavipes.EBI
Korea Research Institute Of Bioscience And Biotechnology
Macrolactins O-R, glycosylated 24-membered lactones from Bacillus sp. AH159-1.EBI
Korea Research Institute Of Bioscience And Biotechnology
Identification of novel potent bicyclic peptide deformylase inhibitors.EBI
Genomics Institute Of The Novartis Research Foundation
2-(2-Oxo-1,4-dihydro-2H-quinazolin-3-yl)- and 2-(2,2-dioxo-1,4-dihydro-2H-2lambda6-benzo[1,2,6]thiadiazin-3-yl)-N-hydroxy-acetamides as potent and selective peptide deformylase inhibitors.EBI
F. Hoffmann-La Roche
Identification of novel potent hydroxamic acid inhibitors of peptidyl deformylase and the importance of the hydroxamic acid functionality on inhibition.EBI
Pharmacia
Discovery of piperazic acid peptide deformylase inhibitors with in vivo activity for respiratory tract and skin infections.EBI
Glaxosmithkline
H-phosphonate derivatives as novel peptide deformylase inhibitors.EBI
Ohio State University
Understanding the origins of time-dependent inhibition by polypeptide deformylase inhibitors.BDB
Glaxosmithkline
Structural variation and inhibitor binding in polypeptide deformylase from four different bacterial species.BDB
Gsk